The role involves analyzing and validating novel immunoassay-based biomarker methods for neurodegenerative diseases such as Alzheimer's and Parkinson's.
Base: $138,000 - $224,400; Bonus/Equity: Eligible for company bonus based on performance; Benefits: Comprehensive program including 401(k), pension, medical, dental, vision, and wellness perks
Must-have
Nice-to-have
Not specified